Home › NDC Lookup › RxCUI directory › RxCUI 308513

Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder — RxCUI 308513

Name: Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder (RxCUI 308513)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 308513 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308513

Official nameBacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbacitracin 500 UNT/GM / polymyxin B 10,000 UNT/GM Topical Powder; bacitracin 500 UNT / polymyxin B 10,000 UNT per GM Topical Powder

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's a first aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and burns. It's not meant for serious or deep wounds — just everyday smal...
What exactly is bacitracin topical used for?
Use a small amount — about the size of the tip of your finger — and apply it to the clean, dry area 1 to 3 times a day. You can put a sterile bandage over it if you like. Don't use...
Not without checking with your doctor first. Bacitracin topical is meant for minor wounds. Deep or puncture wounds, animal bites, and serious burns need a doctor's evaluation — thi...

📖 Read our full Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG To... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder RxCUI 308513 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Bacitracin 1291 IN
- Polymyxin B 8536 IN
- Bacitracin / polymyxin B 645555 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Polysporin 54955 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bacitracin / polymyxin B Topical Powder 374546 SCDF
- Bacitracin / polymyxin B Topical Product 1155354 SCDG
- Bacitracin / polymyxin B Topical Powder [Polysporin] 367478 SBDF
- Polysporin Topical Product 1183534 SBDG
- Topical Powder 317009 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Bacitracin 0.5 UNT/MG 315454 SCDC
- Polymyxin B 10 UNT/MG 328475 SCDC
- Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder [Polysporin] 212240 SBD
- Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG [Polysporin] 572461 SBDC

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Bacitracin 0.5 UNT/MG SCDC · 315454
Polymyxin B 10 UNT/MG SCDC · 328475
Bacitracin / polymyxin B Topical Powder SCDF · 374546
Bacitracin / polymyxin B Topical Product SCDG · 1155354

Brand-Name Concepts

Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Powder [Polysporin] SBD · 212240
Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG [Polysporin] SBDC · 572461
Bacitracin / polymyxin B Topical Powder [Polysporin] SBDF · 367478
Polysporin Topical Product SBDG · 1183534
Polysporin BN · 54955

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 308513 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
48201-0105-75	1 BOTTLE in 1 BOX (48201-105-75) / 7.5 g in 1 BOTTLE	POLVO DE SULFA FIRST AID ANTIBIOTIC	GRANDALL DISTRIBUTING, LLC	2024-07-18
53145-0304-04	7.5 g in 1 BOTTLE, PLASTIC (53145-304-04)	Polvos de Sulpha First Aid Antibiotic	Menper Distributors Inc.	2006-12-11

Observed labelers: GRANDALL DISTRIBUTING, LLC (1) · Menper Distributors Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.